$MANH
Manhattan Associates Inc

2024 Q1 Form 10-K Financial Statement

#000095017024011411 Filed on February 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $254.6M $238.3M $928.7M
YoY Change 15.18% 20.27% 21.07%
Cost Of Revenue $119.3M $106.7M $430.6M
YoY Change 15.11% 18.58% 20.2%
Gross Profit $135.3M $131.5M $498.1M
YoY Change 15.23% 21.67% 21.83%
Gross Profit Margin 53.14% 55.2% 53.63%
Selling, General & Admin $41.13M $39.83M $155.7M
YoY Change 8.19% 14.56% 13.12%
% of Gross Profit 30.41% 30.28% 31.25%
Research & Development $35.01M $31.33M $126.8M
YoY Change 13.69% 15.5% 13.35%
% of Gross Profit 25.88% 23.82% 25.46%
Depreciation & Amortization $1.493M $1.552M $5.752M
YoY Change 0.4% 3.05% -13.67%
% of Gross Profit 1.1% 1.18% 1.15%
Operating Expenses $76.14M $72.66M $282.5M
YoY Change 8.31% 14.62% 10.28%
Operating Profit $57.63M $58.86M $209.9M
YoY Change 22.4% 31.67% 37.45%
Interest Expense $5.904M $6.804M
YoY Change 492.77% 28.47%
% of Operating Profit 10.03% 3.24%
Other Income/Expense, Net $996.0K $867.0K -$1.514M
YoY Change 596.5% 4.71% -127.93%
Pretax Income $58.63M $59.73M $213.7M
YoY Change 24.13% 31.18% 35.13%
Income Tax $4.825M $11.00M $37.10M
% Of Pretax Income 8.23% 18.41% 17.36%
Net Earnings $53.80M $48.74M $176.6M
YoY Change 38.69% 28.7% 36.92%
Net Earnings / Revenue 21.14% 20.46% 19.01%
Basic Earnings Per Share $0.87 $2.86
Diluted Earnings Per Share $0.86 $0.78 $2.82
COMMON SHARES
Basic Shares Outstanding 61.57M 61.57M 61.82M
Diluted Shares Outstanding 62.49M 62.61M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $207.5M $270.7M $270.7M
YoY Change 14.28% 20.08% 20.08%
Cash & Equivalents $207.5M $270.7M $270.7M
Short-Term Investments
Other Short-Term Assets $31.98M $5.195M $27.28M
YoY Change 9.0% -77.55% 17.85%
Inventory
Prepaid Expenses $20.71M
Receivables $205.7M $181.2M $181.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $445.2M $479.2M $479.2M
YoY Change 19.84% 15.36% 15.36%
LONG-TERM ASSETS
Property, Plant & Equipment $12.68M $11.80M $33.44M
YoY Change -56.3% -61.45% 9.29%
Goodwill $62.23M $62.24M
YoY Change 0.0% 0.01%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $32.74M $32.45M $98.49M
YoY Change -51.91% -47.65% 58.91%
Total Long-Term Assets $229.6M $194.2M $194.2M
YoY Change 44.07% 25.43% 25.43%
TOTAL ASSETS
Total Short-Term Assets $445.2M $479.2M $479.2M
Total Long-Term Assets $229.6M $194.2M $194.2M
Total Assets $674.8M $673.4M $673.4M
YoY Change 27.11% 18.1% 18.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.40M $24.51M $24.51M
YoY Change 4.12% -4.64% -4.64%
Accrued Expenses $73.44M $100.6M $100.6M
YoY Change 4.53% 27.26% 27.26%
Deferred Revenue $263.9M $237.8M
YoY Change 22.0% 13.88%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $372.0M $365.9M $365.9M
YoY Change 15.26% 15.94% 15.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.32M $11.47M $29.16M
YoY Change -58.09% -58.73% 4.96%
Total Long-Term Liabilities $11.32M $11.47M $29.16M
YoY Change -58.09% -58.73% 4.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $372.0M $365.9M $365.9M
Total Long-Term Liabilities $11.32M $11.47M $29.16M
Total Liabilities $383.3M $377.4M $395.1M
YoY Change 9.6% 9.9% 15.06%
SHAREHOLDERS EQUITY
Retained Earnings $266.8M $304.7M
YoY Change 28.76% 20.1%
Common Stock $615.0K $615.0K
YoY Change -0.81% -0.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $239.6M $278.3M $278.3M
YoY Change
Total Liabilities & Shareholders Equity $674.8M $673.4M $673.4M
YoY Change 27.11% 18.1% 18.1%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $53.80M $48.74M $176.6M
YoY Change 38.69% 28.7% 36.92%
Depreciation, Depletion And Amortization $1.493M $1.552M $5.752M
YoY Change 0.4% 3.05% -13.67%
Cash From Operating Activities $54.74M $88.32M $246.2M
YoY Change -6.72% 59.92% 37.07%
INVESTING ACTIVITIES
Capital Expenditures $2.321M $1.930M $4.730M
YoY Change 248.5% -179.26% -171.81%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.321M -$1.930M -$4.730M
YoY Change 248.5% -20.74% -28.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $196.0M
YoY Change -195.89%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -113.8M -347.0K -196.0M
YoY Change 11.94% -98.64% -4.11%
NET CHANGE
Cash From Operating Activities 54.74M 88.32M 246.2M
Cash From Investing Activities -2.321M -1.930M -4.730M
Cash From Financing Activities -113.8M -347.0K -196.0M
Net Change In Cash -63.22M 86.04M 45.28M
YoY Change 44.76% 214.45% -244.12%
FREE CASH FLOW
Cash From Operating Activities $54.74M $88.32M $246.2M
Capital Expenditures $2.321M $1.930M $4.730M
Free Cash Flow $52.42M $86.39M $241.5M
YoY Change -9.65% 49.82% 29.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001056696
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.manh.com/20231231#AccruedAndOtherLiabilitiesCurrent
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-23999
CY2023 dei Entity Registrant Name
EntityRegistrantName
Manhattan Associates, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-2373424
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Windy Ridge Parkway
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Tenth Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2023 dei City Area Code
CityAreaCode
770
CY2023 dei Local Phone Number
LocalPhoneNumber
955-7070
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value per share
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
12326302179
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.86
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.05
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.74
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61566215
CY2023 dei Trading Symbol
TradingSymbol
MANH
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
928725000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
767084000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
663643000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126814000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
111877000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97628000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
74490000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
64537000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
57855000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
81174000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73070000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68086000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5752000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6663000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7914000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
718844000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
614384000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
529310000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
209881000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
152700000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
134333000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5304000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
596000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
68000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1514000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4825000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-329000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
213671000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
158121000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
134072000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37103000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29162000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23600000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
176568000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
128959000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
110472000
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.82
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61817000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62768000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63445000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62608000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63408000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64323000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
176568000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
128959000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
110472000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
494000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7704000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1566000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
177062000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
121255000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
108906000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
270741000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225463000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
181173000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
166767000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1371000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
647000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20710000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18884000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5195000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3614000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
479190000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
415375000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11795000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12803000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21645000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17794000
CY2023Q4 us-gaap Goodwill
Goodwill
62235000
CY2022Q4 us-gaap Goodwill
Goodwill
62230000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
66043000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37206000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32445000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24770000
CY2023Q4 us-gaap Assets
Assets
673353000
CY2022Q4 us-gaap Assets
Assets
570178000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24508000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25701000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
73210000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54469000
CY2023Q4 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
27374000
CY2022Q4 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
24569000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
237793000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
208807000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3030000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2049000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
365915000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
315595000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17694000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14065000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11466000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13718000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61566037
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61566037
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62191570
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62191570
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
615000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
621000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
304701000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
253711000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27038000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27532000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278278000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
226800000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
673353000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
570178000
CY2023 us-gaap Profit Loss
ProfitLoss
176568000
CY2022 us-gaap Profit Loss
ProfitLoss
128959000
CY2021 us-gaap Profit Loss
ProfitLoss
110472000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5752000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6663000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7914000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
71571000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
59361000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
43259000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-57000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
89000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7000
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-28844000
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-29711000
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1912000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1280000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1515000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
493000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13084000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
44056000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16650000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10925000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10247000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6533000
CY2023 manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
18123000
CY2022 manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
11794000
CY2021 manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
12256000
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1416000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
765000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3667000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
27136000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
57706000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
40530000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
246218000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
179630000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
185183000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4730000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6587000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4016000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4730000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6587000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4016000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
196047000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
204460000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
120418000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-196047000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-204460000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-120418000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-163000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6826000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1748000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45278000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38243000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
59001000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
225463000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
263706000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
204705000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
270741000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
225463000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
263706000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
67376000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
58022000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
29162000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
218897000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
120418000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
43259000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1566000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
110472000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
250644000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
204460000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
59361000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7704000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
128959000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
226800000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
196047000
CY2023 manh Excise Tax Accrued
ExciseTaxAccrued
1108000
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
71571000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
494000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
176568000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278278000
CY2023 manh Principles Of Consolidation And Foreign Currency Translation Policy Textblock
PrinciplesOfConsolidationAndForeignCurrencyTranslationPolicyTextblock
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principles of Consolidation and Foreign Currency Translation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The financial statements of foreign subsidiaries have been translated into United States dollars in accordance with the foreign currency matters topic in the Financial Accounting Standards Board's (FASB) Accounting Standards Codification (the “Codification”). Revenues and expenses from international operations were denominated in the respective local currencies and translated using the average monthly exchange rates for the year. All balance sheet accounts have been translated using the exchange rates in effect at the balance sheet date and the effect of changes in exchange rates from year to year are disclosed as a separate component of shareholders’ equity and comprehensive income.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize revenue on approximately 40% of these remaining performance obligations over the next 24 months with the majority of the remaining balance recognized over the following 36 months.
CY2023 manh Expected Percentage Of Revenue Recognized From Remaining Performance Obligation Over Twenty Four Months
ExpectedPercentageOfRevenueRecognizedFromRemainingPerformanceObligationOverTwentyFourMonths
0.40
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:2.253%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. We maintain cash and cash equivalents with various financial institutions. Amounts held are above the federally insured limit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our sales are primarily to companies located in the United States, Europe and Asia. We perform periodic credit evaluations of our customers’ financial condition and do not require collateral. Accounts receivable are due principally from large U.S., European and Asia Pacific companies under stated contract terms. Accounts receivable, net as of December 31, 2023 for the Americas, EMEA, and APAC segments were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">137.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">34.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. Accounts receivable, net as of December 31, 2022 for the Americas, EMEA, and APAC segments were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">133.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">28.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. Our top five customers in aggregate accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of total revenue recognized for each of the years ended December 31, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023 (“2023”), the year ended December 31, 2022 (“2022”), and the year ended December 31, 2021 (“2021</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">”), respectively. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> single customer accounted for more than 10% of revenue in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023, 2022 and 2021, or more than 10% of accounts receivable as of December 31, 2023 and 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023 manh Percentage Of Revenue Accounted For By Top Five Customers
PercentageOfRevenueAccountedForByTopFiveCustomers
0.11
CY2022 manh Percentage Of Revenue Accounted For By Top Five Customers
PercentageOfRevenueAccountedForByTopFiveCustomers
0.11
CY2021 manh Percentage Of Revenue Accounted For By Top Five Customers
PercentageOfRevenueAccountedForByTopFiveCustomers
0.12
CY2023 manh Number Of Single Customers Accounting For More Than Ten Percent Of Revenue
NumberOfSingleCustomersAccountingForMoreThanTenPercentOfRevenue
0
CY2022 manh Number Of Single Customers Accounting For More Than Ten Percent Of Revenue
NumberOfSingleCustomersAccountingForMoreThanTenPercentOfRevenue
0
CY2023 manh Number Of Single Customers Accounting For More Than Ten Percent Of Accounts Receivable
NumberOfSingleCustomersAccountingForMoreThanTenPercentOfAccountsReceivable
0
CY2022 manh Number Of Single Customers Accounting For More Than Ten Percent Of Accounts Receivable
NumberOfSingleCustomersAccountingForMoreThanTenPercentOfAccountsReceivable
0
CY2021 manh Number Of Single Customers Accounting For More Than Ten Percent Of Revenue
NumberOfSingleCustomersAccountingForMoreThanTenPercentOfRevenue
0
CY2023Q4 us-gaap Cash
Cash
184500000
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
86200000
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
79700000
CY2023Q4 us-gaap Investments
Investments
0
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:2.253%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates include the allowance for credit losses, which is based upon an evaluation of historical amounts written-off, the customers’ ability to pay, and general economic conditions; self-insurance accruals; impairment testing of goodwill; and our effective income tax rate (including the impact of unrecognized tax benefits) and deferred tax assets, which are based upon our expectations of future taxable income, allowable deductions, and projected tax credits. Actual results will differ from these estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1400000000
CY2023Q4 manh Percentage Of Remaining Performance Obligation To Be Recognized As Cloud Revenue
PercentageOfRemainingPerformanceObligationToBeRecognizedAsCloudRevenue
0.98
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
900000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
600000
CY2023Q4 manh Other Provisions For Doubtful Accounts Valuation Allowance
OtherProvisionsForDoubtfulAccountsValuationAllowance
4400000
CY2022Q4 manh Other Provisions For Doubtful Accounts Valuation Allowance
OtherProvisionsForDoubtfulAccountsValuationAllowance
5400000
CY2023 us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
We apply the practical expedient to expense sales commissions when the amortization period would have been one year or less.
CY2023 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
9800000
CY2022 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
7500000
CY2021 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
5200000
CY2023 us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2021 us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2022 us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5800000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6700000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7900000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68926000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67662000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
57131000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
54859000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11795000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12803000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023 us-gaap Net Income Loss
NetIncomeLoss
176568000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
128959000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
110472000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.86
CY2023Q4 manh Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Sales Taxes
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedSalesTaxes
189000
CY2022Q4 manh Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Sales Taxes
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedSalesTaxes
190000
CY2023Q4 manh Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Operating Lease Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOperatingLeaseLiabilities
3219000
CY2022Q4 manh Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Operating Lease Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOperatingLeaseLiabilities
2974000
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2022Q4 us-gaap Goodwill
Goodwill
62200000
CY2023Q4 us-gaap Goodwill
Goodwill
62200000
CY2023 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="margin-left:2.253%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Guarantees and Indemnities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We account for guarantees in accordance with the guarantee accounting topic in the FASB Codification</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Our customer contracts generally contain infringement indemnity provisions. Under those provisions, we generally agree, subject to certain exceptions, to indemnify, defend, and hold harmless the customer in connection with third party claims against the customer alleging that the customer’s use of our software products in compliance with their license infringe the third party’s patent, copyright, or other intellectual property rights. Conditions to our obligations generally include that we are provided the right to control the defense of the claims and, in general, to control settlement negotiations. Those provisions generally provide also that, if the customer is prevented from using our software because of a third party infringement claim, our sole obligation (in addition to the indemnification, defense, and hold harmless obligation referred to above) is to, at our expense, (i) procure for the customer the right to continue to use the software, (ii) replace or modify the product so that its use by the customer does not infringe, or, if either of the foregoing are not reasonably feasible, (iii) terminate the customer contract and provide a refund of the unamortized portion of the customer’s license fee (based on a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">five year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> amortization period). Our customer contracts sometimes also require us to indemnify, defend, and hold harmless the customer in connection with death, personal injury, or property damage claims made by third parties with respect to actions of our personnel or contractors. The indemnity obligations contained in our customer contracts generally have no specified expiration date and no specified monetary limitation on liability. We have not previously incurred costs to settle claims or pay awards under these indemnification obligations. We account for these indemnity obligations in accordance with FASB guidance on accounting for contingencies, and record a liability for these obligations when a loss is probable and reasonably estimable. We have not recorded any liabilities for these contracts as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023, or 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:2.267%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In general, in our customer contracts for purchase of our cloud SaaS services or license of our on-premises software products, we warrant that our services or software will perform in accordance with our published services or product specifications. Additionally, we may include other warranties such as “no-malware” warranties and warranties that we will perform our SaaS services consistent with generally accepted industry standards or similar standards. We also warrant to our customers that services will be performed consistent with generally accepted industry standards or specific service levels through completion of the agreed upon services. If necessary, we will provide for the estimated cost of product and service warranties based on specific warranty claims history. However, we have not incurred significant recurring expenses under product or service warranties. As a result, we believe the estimated fair value of these agreements is nominal. Accordingly, we have no liabilities recorded for these agreements as of December 31, 2023 and 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023 manh Amortization Period
AmortizationPeriod
P5Y
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.05
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.74
CY2023 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.04
CY2022 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
CY2021 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.82
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61817000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62768000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63445000
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
791000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
640000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
878000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62608000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63408000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64323000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3102000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2700000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
5397000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
3108000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2881000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2735000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
295000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
279000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
2400000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
2300000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
2300000
CY2023 us-gaap Restricted Stock Expense
RestrictedStockExpense
71600000
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
59400000
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
43300000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1179000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1321000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
12255000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
9208000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
12148000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9832000
CY2023Q4 manh Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Capitalized Costs
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedCosts
50654000
CY2022Q4 manh Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Capitalized Costs
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedCosts
27516000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
85557000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
54393000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
7417000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
7428000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
429000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
580000
CY2023Q4 manh Deferred Tax Liabilities Deferred Commissions
DeferredTaxLiabilitiesDeferredCommissions
8638000
CY2022Q4 manh Deferred Tax Liabilities Deferred Commissions
DeferredTaxLiabilitiesDeferredCommissions
6408000
CY2023Q4 manh Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
3030000
CY2022Q4 manh Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
2771000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
19514000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
17187000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
66043000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
37206000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
193727000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
139217000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
120565000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
19944000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
18904000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
13507000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
213671000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
158121000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
134072000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
46497000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
42198000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
14042000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10911000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
11183000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5188000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
8539000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5492000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
6309000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
65947000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
58873000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
25539000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-23116000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-22383000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-427000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3132000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-5200000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-531000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2596000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2128000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-981000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-28844000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-29711000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1939000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37103000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29162000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23600000
CY2023 manh Increase Decrease In Earnings Per Share Diluted
IncreaseDecreaseInEarningsPerShareDiluted
-0.04
CY2023Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
3900000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3100000
CY2023Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
1500000
CY2023Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
90400000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.03
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.036
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.036
CY2023 manh Effective Income Tax Rate Reconciliation State Tax Credits Adjustment
EffectiveIncomeTaxRateReconciliationStateTaxCreditsAdjustment
0.002
CY2022 manh Effective Income Tax Rate Reconciliation State Tax Credits Adjustment
EffectiveIncomeTaxRateReconciliationStateTaxCreditsAdjustment
-0.012
CY2021 manh Effective Income Tax Rate Reconciliation State Tax Credits Adjustment
EffectiveIncomeTaxRateReconciliationStateTaxCreditsAdjustment
0.008
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.018
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.018
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.018
CY2023 manh Effective Income Tax Rate Reconciliation Nondeductible Equity Compensation
EffectiveIncomeTaxRateReconciliationNondeductibleEquityCompensation
0.011
CY2022 manh Effective Income Tax Rate Reconciliation Nondeductible Equity Compensation
EffectiveIncomeTaxRateReconciliationNondeductibleEquityCompensation
0.011
CY2021 manh Effective Income Tax Rate Reconciliation Nondeductible Equity Compensation
EffectiveIncomeTaxRateReconciliationNondeductibleEquityCompensation
0.009
CY2023 manh Effective Income Tax Rate Reconciliation Excess Benefit Of Equity Compensation
EffectiveIncomeTaxRateReconciliationExcessBenefitOfEquityCompensation
0.032
CY2022 manh Effective Income Tax Rate Reconciliation Excess Benefit Of Equity Compensation
EffectiveIncomeTaxRateReconciliationExcessBenefitOfEquityCompensation
0.048
CY2021 manh Effective Income Tax Rate Reconciliation Excess Benefit Of Equity Compensation
EffectiveIncomeTaxRateReconciliationExcessBenefitOfEquityCompensation
0.049
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.034
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.037
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.034
CY2023 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.002
CY2023 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
0.036
CY2022 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
0.033
CY2021 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
0.031
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.029
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.007
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.003
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.007
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.007
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.174
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.176
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10532000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13186000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12804000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
425000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
199000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
408000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
908000
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
2583000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
147000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2182000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1787000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3117000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
148000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2543000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2057000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2848000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9688000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10532000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13186000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9700000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10500000
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9100000
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9900000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
100000
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
700000
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
400000
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1300000
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1200000
CY2023Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
3200000
CY2023 manh Stock Repurchased Under Publicly Announced Share Repurchase Program During Period Shares
StockRepurchasedUnderPubliclyAnnouncedShareRepurchaseProgramDuringPeriodShares
1024328
CY2022 manh Stock Repurchased Under Publicly Announced Share Repurchase Program During Period Shares
StockRepurchasedUnderPubliclyAnnouncedShareRepurchaseProgramDuringPeriodShares
1352954
CY2021 manh Stock Repurchased Under Publicly Announced Share Repurchase Program During Period Shares
StockRepurchasedUnderPubliclyAnnouncedShareRepurchaseProgramDuringPeriodShares
709200
CY2023 manh Stock Repurchased Under Publicly Announced Share Repurchase Program During Period Value
StockRepurchasedUnderPubliclyAnnouncedShareRepurchaseProgramDuringPeriodValue
166000000
CY2022 manh Stock Repurchased Under Publicly Announced Share Repurchase Program During Period Value
StockRepurchasedUnderPubliclyAnnouncedShareRepurchaseProgramDuringPeriodValue
175400000
CY2021 manh Stock Repurchased Under Publicly Announced Share Repurchase Program During Period Value
StockRepurchasedUnderPubliclyAnnouncedShareRepurchaseProgramDuringPeriodValue
100000000
CY2023Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000
CY2023 manh Effective Income Tax Rate Reconciliation Nondeductible Excise Tax On Stock Repurchases
EffectiveIncomeTaxRateReconciliationNondeductibleExciseTaxOnStockRepurchases
0.01
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
22500
CY2023 manh Employee Compensation Limit
EmployeeCompensationLimit
330000
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2023 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
7800000
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
6700000
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
5200000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
24100000
CY2023 manh Option To Extend Lease Term
OptionToExtendLeaseTerm
P10Y
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21645000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6428000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17694000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
24122000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7096000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6729000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3690000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3769000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3823000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
735000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
25842000
CY2023Q4 manh Short Term Lease
ShortTermLease
97000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1623000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
24122000
CY2023 us-gaap Lease Cost
LeaseCost
8100000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
7800000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000
CY2022 us-gaap Lease Cost
LeaseCost
7700000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
7300000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000
CY2021 us-gaap Lease Cost
LeaseCost
7900000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
7500000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
7016000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
928725000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
767084000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
430614000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
358237000
CY2023 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
282478000
CY2022 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
249484000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5752000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6663000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
718844000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
614384000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
209881000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
152700000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
663643000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
297827000
CY2021 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
223569000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7914000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
529310000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
134333000
CY2023Q4 us-gaap Goodwill
Goodwill
62235000
CY2022Q4 us-gaap Goodwill
Goodwill
62230000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
65886000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
55367000
CY2023Q4 us-gaap Assets
Assets
673353000
CY2022Q4 us-gaap Assets
Assets
570178000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-011411-index-headers.html Edgar Link pending
0000950170-24-011411-index.html Edgar Link pending
0000950170-24-011411.txt Edgar Link pending
0000950170-24-011411-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img216941502_0.jpg Edgar Link pending
manh-20231231.htm Edgar Link pending
manh-20231231.xsd Edgar Link pending
manh-ex10_1.htm Edgar Link pending
manh-ex10_41.htm Edgar Link pending
manh-ex10_51.htm Edgar Link pending
manh-ex19_1.htm Edgar Link pending
manh-ex23_1.htm Edgar Link pending
manh-ex31_1.htm Edgar Link pending
manh-ex31_2.htm Edgar Link pending
manh-ex32.htm Edgar Link pending
manh-ex97_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
manh-20231231_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending